Group 1 - RH reported weaker-than-expected second-quarter results with earnings of $2.93 per share, below the analyst estimate of $3.20, and revenue of $899.15 million, missing the Street estimate of $904.64 million [1] - Despite challenges, RH experienced industry-leading growth with a revenue increase of 8.4% and demand growth of 13.7% in the second quarter [2] - RH lowered its fiscal 2025 revenue outlook from a range of $3.49 billion to $3.59 billion to a new range of $3.46 billion to $3.53 billion, compared to the previous estimate of $3.52 billion [2] Group 2 - Following the earnings announcement, analysts adjusted their price targets for RH, with Telsey Advisory Group downgrading from Outperform to Market Perform and lowering the price target from $255 to $220 [8] - Barclays maintained an Overweight rating but reduced the price target from $436 to $385 [8] - Guggenheim reiterated a Buy rating and maintained a price target of $300 [8]
RH Analysts Slash Their Forecasts Following Downbeat Q2 Results